Columbia University
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1754-01-01
- Employees
- 20.8K
- Market Cap
- -
Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors
- Conditions
- First Posted Date
- 2009-06-30
- Last Posted Date
- 2014-07-23
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 10
- Registration Number
- NCT00930527
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer
- Conditions
- Interventions
- First Posted Date
- 2009-04-16
- Last Posted Date
- 2016-07-25
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 37
- Registration Number
- NCT00882310
Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
- Conditions
- Interventions
- First Posted Date
- 2009-04-15
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 3
- Registration Number
- NCT00881556
- Locations
- 🇺🇸
The Children's Hospital, Aurora, Colorado, United States
🇺🇸Morgan Stanley Children's Hospital of NYP, New York, New York, United States
🇺🇸Children's Memorial Hospital, Chicago, Illinois, United States
PANDA (Pediatric Anesthesia & NeuroDevelopment Assessment) Study
- Conditions
- Interventions
- First Posted Date
- 2009-04-15
- Last Posted Date
- 2023-02-17
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 369
- Registration Number
- NCT00881764
- Locations
- 🇺🇸
Columbia University, 622 W. 168th St., New York, New York, United States
🇺🇸The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
Capecitabine and Temozolomide for Neuroendocrine Cancers
- First Posted Date
- 2009-03-25
- Last Posted Date
- 2016-07-25
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 41
- Registration Number
- NCT00869050
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar
- Conditions
- Interventions
- First Posted Date
- 2009-03-25
- Last Posted Date
- 2016-06-22
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 32
- Registration Number
- NCT00869258
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
GTX Regimen for Biliary Cancers
- Conditions
- Interventions
- First Posted Date
- 2009-03-25
- Last Posted Date
- 2016-05-23
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 4
- Registration Number
- NCT00868998
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
Alimta Plus Gemcitabine for Advanced Sarcoma
- First Posted Date
- 2009-03-11
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 12
- Registration Number
- NCT00860015
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
Trimodal Lung-Sparing Treatment of Pleural Mesothelioma
- Conditions
- Interventions
- First Posted Date
- 2009-03-11
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 9
- Registration Number
- NCT00859495
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma
- First Posted Date
- 2009-03-11
- Last Posted Date
- 2019-10-30
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 29
- Registration Number
- NCT00859469
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States